6.
Stokking L, Ehrhart E, Lichtensteiger C, Campbell K
. Pigmented epidermal plaques in three dogs. J Am Anim Hosp Assoc. 2004; 40(5):411-7.
DOI: 10.5326/0400411.
View
7.
Cosgrove S, Cleaver D, King V, Gilmer A, Daniels A, Wren J
. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015; 26(3):171-9, e35.
DOI: 10.1111/vde.12194.
View
8.
Callan M, Preziosi D, Mauldin E
. Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine. Vet Dermatol. 2005; 16(5):338-45.
DOI: 10.1111/j.1365-3164.2005.00466.x.
View
9.
Nicholls P, Klaunberg B, Moore R, Santos E, Parry N, Gough G
. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology. 1999; 265(2):365-74.
DOI: 10.1006/viro.1999.0060.
View
10.
Ferrer L, Ravera I, Silbermayr K
. Immunology and pathogenesis of canine demodicosis. Vet Dermatol. 2014; 25(5):427-e65.
DOI: 10.1111/vde.12136.
View
11.
Steffan J, Favrot C, Mueller R
. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol. 2006; 17(1):3-16.
DOI: 10.1111/j.1365-3164.2005.00491.x.
View
12.
Munday J, Kiupel M
. Papillomavirus-associated cutaneous neoplasia in mammals. Vet Pathol. 2010; 47(2):254-64.
DOI: 10.1177/0300985809358604.
View
13.
Bredal W, Thoresen S, Rimstad E, Aleksandersen M, Nafstad P
. Diagnosis and clinical course of canine oral papillomavirus infection. J Small Anim Pract. 1996; 37(3):138-42.
DOI: 10.1111/j.1748-5827.1996.tb02364.x.
View
14.
Kuntsi-Vaattovaara H, Verstraete F, Newsome J, Yuan H
. Resolution of persistent oral papillomatosis in a dog after treatment with a recombinant canine oral papillomavirus vaccine. Vet Comp Oncol. 2009; 1(1):57-63.
DOI: 10.1046/j.1476-5829.2003.00005.x.
View
15.
Thaiwong T, Sledge D, Wise A, Olstad K, Maes R, Kiupel M
. Malignant transformation of canine oral papillomavirus (CPV1)-associated papillomas in dogs: An emerging concern?. Papillomavirus Res. 2018; 6:83-89.
PMC: 6260289.
DOI: 10.1016/j.pvr.2018.10.007.
View
16.
Delius H, Van Ranst M, Jenson A, zur Hausen H, Sundberg J
. Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology. 1994; 204(1):447-52.
DOI: 10.1006/viro.1994.1552.
View
17.
Porcellato I, Brachelente C, Guelfi G, Reginato A, Sforna M, Bongiovanni L
. A retrospective investigation on canine papillomavirus 1 (CPV1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk HPV-induced oral cancer. PLoS One. 2014; 9(11):e112833.
PMC: 4234530.
DOI: 10.1371/journal.pone.0112833.
View
18.
Teifke J, Lohr C, Shirasawa H
. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Vet Microbiol. 1998; 60(2-4):119-30.
DOI: 10.1016/s0378-1135(98)00151-5.
View
19.
Gil da Costa R, Peleteiro M, Pires M, DiMaio D
. An Update on Canine, Feline and Bovine Papillomaviruses. Transbound Emerg Dis. 2016; 64(5):1371-1379.
DOI: 10.1111/tbed.12555.
View
20.
Knight E, Munday J, Stone B, Shipstone M
. Carbon dioxide laser treatment of extensive pigmented viral plaque lesions in a golden retriever dog. Vet Dermatol. 2016; 27(5):442-e117.
DOI: 10.1111/vde.12350.
View